Biotech Blockchain Technology 
TechCrunch
APRIL 8, 2022
“As your technology becomes more dated, you too will have to make similar decisions.” 6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. ” Thanks very much for reading — have a great weekend!
Dzone - DevOps
MARCH 20, 2025
Multidomain integration is becoming a cornerstone of modern software development, bridging technologies like blockchain, biotech, and consumer applications. These cross-domain projects are no longer optional they are the future of innovation. However, combining such diverse systems presents unique challenges.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
APRIL 27, 2022
Dragonfly plans to focus its investments across all stages of blockchain and crypto-native companies, protocols, and tokens. “We It’s really important to have that technical fundamental knowledge when investing into early-stage crypto technology,” Qureshi said. You’d be missing the core mechanics of what you’re investing in.”.
TechCrunch
DECEMBER 28, 2021
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Blockchain NZ Chair Bryan Ventura. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space.
TechCrunch
OCTOBER 25, 2022
Jacob Sonnenberg is a portfolio manager at Irving Investors and runs Irving's Technology and Consumer Crossover Fund. billion in its fourth fund targeting blockchain, bringing its total funds raised for blockchain-related companies to more than $7.6 billion allocated to biotech investments. Jacob Sonnenberg. Contributor.
TechCrunch
APRIL 3, 2023
“We seek out exceptional founding teams whose business plan is centered on the strategic utilization of technology to gain a competitive advantage. The technology sector has faced some short- to mid-term pressure globally due to recent market adjustments. We don’t limit ourselves to any specific sector,” Kazah said.
Crunchbase News
MAY 2, 2024
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. A startup needed to raise $200 million or more to break into this list for the April edition. Let’s take a look.
Expert insights. Personalized for you.
222 
Let's personalize your content